NO943723D0 - Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes - Google Patents
Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetesInfo
- Publication number
- NO943723D0 NO943723D0 NO943723A NO943723A NO943723D0 NO 943723 D0 NO943723 D0 NO 943723D0 NO 943723 A NO943723 A NO 943723A NO 943723 A NO943723 A NO 943723A NO 943723 D0 NO943723 D0 NO 943723D0
- Authority
- NO
- Norway
- Prior art keywords
- quinoline
- diabetes
- treatment
- carboxamide compounds
- carboxamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9201076A SE9201076L (sv) | 1992-04-06 | 1992-04-06 | Användningen av gamla läkemedel för behandling av diabetes |
| PCT/SE1993/000272 WO1993019756A1 (en) | 1992-04-06 | 1993-03-31 | The use of quinoline-3-carboxamide compounds for treatment of diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO943723L NO943723L (no) | 1994-10-05 |
| NO943723D0 true NO943723D0 (no) | 1994-10-05 |
Family
ID=20385863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943723A NO943723D0 (no) | 1992-04-06 | 1994-10-05 | Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5594005A (et) |
| EP (1) | EP0634931A1 (et) |
| JP (1) | JPH07506568A (et) |
| KR (1) | KR950700738A (et) |
| CN (1) | CN1081671A (et) |
| AU (1) | AU667362B2 (et) |
| CA (1) | CA2131831C (et) |
| EE (1) | EE03090B1 (et) |
| HU (1) | HUT69710A (et) |
| IL (1) | IL105285A0 (et) |
| NO (1) | NO943723D0 (et) |
| NZ (1) | NZ251494A (et) |
| PH (1) | PH30820A (et) |
| SE (1) | SE9201076L (et) |
| WO (1) | WO1993019756A1 (et) |
| ZA (1) | ZA932450B (et) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9802550D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
| US6133285A (en) * | 1998-07-15 | 2000-10-17 | Active Biotech Ab | Quinoline derivatives |
| SE9802549D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
| FR2827600A1 (fr) * | 2001-07-20 | 2003-01-24 | Lipha | Derives acides de quinolone et leurs applications en therapeutique |
| US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US8653143B2 (en) * | 2008-10-09 | 2014-02-18 | Newtree Co., Ltd. | Use of panduratin derivative or Boesenbergia pandurata extract |
| CN103153959A (zh) | 2010-10-14 | 2013-06-12 | 伊姆纳尔公司 | 作为AhR活化剂的1，2-二氢-4-羟基-2-氧代-喹啉-3-甲酰苯胺类 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1034124A (en) * | 1973-05-11 | 1978-07-04 | Ciba-Geigy Ag | Process for the manufacture of new quinolines |
| FR2340735A1 (fr) * | 1976-02-11 | 1977-09-09 | Roussel Uclaf | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
| IE52670B1 (en) * | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
| DE3134780A1 (de) * | 1981-09-02 | 1983-03-10 | Hoechst Ag, 6000 Frankfurt | "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung" |
| US5310913A (en) * | 1989-06-09 | 1994-05-10 | Kabi Pharmacia Aktiebolag | Derivatives of quinoline-3-carboxanilide |
| SE9000624D0 (sv) * | 1990-02-22 | 1990-02-22 | Pharmacia Ab | New use |
| SE9001111D0 (sv) * | 1990-03-27 | 1990-03-27 | Pharmacia Ab | Supportive use |
-
1992
- 1992-04-06 SE SE9201076A patent/SE9201076L/xx not_active Application Discontinuation
-
1993
- 1993-03-31 WO PCT/SE1993/000272 patent/WO1993019756A1/en not_active Application Discontinuation
- 1993-03-31 JP JP5517372A patent/JPH07506568A/ja active Pending
- 1993-03-31 EP EP93908245A patent/EP0634931A1/en not_active Withdrawn
- 1993-03-31 HU HU9402854A patent/HUT69710A/hu unknown
- 1993-03-31 NZ NZ251494A patent/NZ251494A/en unknown
- 1993-03-31 CA CA002131831A patent/CA2131831C/en not_active Expired - Fee Related
- 1993-03-31 US US08/313,302 patent/US5594005A/en not_active Expired - Fee Related
- 1993-03-31 AU AU39131/93A patent/AU667362B2/en not_active Ceased
- 1993-04-02 PH PH45991A patent/PH30820A/en unknown
- 1993-04-02 IL IL105285A patent/IL105285A0/xx unknown
- 1993-04-05 CN CN93105195A patent/CN1081671A/zh active Pending
- 1993-04-05 ZA ZA932450A patent/ZA932450B/xx unknown
-
1994
- 1994-10-05 NO NO943723A patent/NO943723D0/no unknown
- 1994-10-06 KR KR1019940703534A patent/KR950700738A/ko not_active Application Discontinuation
- 1994-11-17 EE EE9400269A patent/EE03090B1/et unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1081671A (zh) | 1994-02-09 |
| NZ251494A (en) | 1997-07-27 |
| KR950700738A (ko) | 1995-02-20 |
| NO943723L (no) | 1994-10-05 |
| CA2131831C (en) | 1999-03-09 |
| PH30820A (en) | 1997-10-17 |
| IL105285A0 (en) | 1993-08-18 |
| SE9201076D0 (sv) | 1992-04-06 |
| CA2131831A1 (en) | 1993-10-14 |
| EP0634931A1 (en) | 1995-01-25 |
| AU3913193A (en) | 1993-11-08 |
| JPH07506568A (ja) | 1995-07-20 |
| ZA932450B (en) | 1993-10-20 |
| WO1993019756A1 (en) | 1993-10-14 |
| AU667362B2 (en) | 1996-03-21 |
| HU9402854D0 (en) | 1995-01-30 |
| EE03090B1 (et) | 1998-06-15 |
| SE9201076L (sv) | 1993-10-07 |
| US5594005A (en) | 1997-01-14 |
| HUT69710A (en) | 1995-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO934304L (no) | Fremgangsmaate for behandling av fluoralumosilikatglass | |
| NO976063D0 (no) | Fremgangsmåte for behandling av diabetes | |
| NO924461D0 (no) | Dipyridamol for behandling av proliferaktive sykdommer | |
| NO952573D0 (no) | Blandinger for behandling av diabetiske komplikasjoner | |
| NO921777L (no) | Fremgangsmaate for fremstilling av isoparaffiner | |
| NO914825L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme alfa-oxoacetamider | |
| AU1532492A (en) | Use of heterocyclic compounds for the treatment of inflammatory pain | |
| NO912411D0 (no) | Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser. | |
| FI921260A (fi) | Faestanordning foer loeslagbar anslutning av tvao profilstycken | |
| NO910395L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater. | |
| NO953254D0 (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
| NO933904L (no) | Fremgangsmåte for fremstilling av aromatiske brommetylforbindelser | |
| NO912797L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater. | |
| NO930574L (no) | Fremgangsmaate for fremstilling av desfluran | |
| NO943723D0 (no) | Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes | |
| NO913117D0 (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
| FI963532A (fi) | Kinoliini-3-karboksamidiyhdisteiden uusi käyttö | |
| NO913692D0 (no) | Fremgangsmaate for fremstilling av karbapenemforbindelser. | |
| NO920983L (no) | Fremgangsmaate for behandling av nevrodegenerative tilstander | |
| FI963531A0 (fi) | Kinoliini-3-karboksamidiyhdisteiden uusi käyttö | |
| NO173871C (no) | Fremgangsmaate for fremstilling av penemforbindelser | |
| NO903397L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd. | |
| KR890701106A (ko) | 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도 | |
| NO920033D0 (no) | Fremgangsmaate for fremstilling av heterocykliske forbindelser | |
| NO905643L (no) | Fremgangsmaate for behandling av manganslam. |